BioSpace News Archive

Applied Molecular Transport Inc. (Nasdaq: AMTI) (AMT), a clinical-stage biopharmaceutical company, today announced the pricing of an underwritten public offering of 2,500,000 shares of its common stock at a public offering price of $42.00 per share

Identiv, Inc., a global leader in digital identification and security, announced it is awarded “Supplier of the Year” by Schreiner Group GmbH & Co. KG for its innovative device-level authentication, anti-counterfeiting RFID devices in medical equipment and consumables.

Takeda Pharmaceutical Company Limited ( TSE:4502/NYSE:TAK ) (“Takeda”) today announced the completion of its previously-announced sale of a portfolio of select products to Orifarm Group (“Orifarm”) for a total value of up to $670 million USD. The portfolio includes approximately 130 over-the-counter (OTC) and prescription pharmaceutical products sold in Europe, and two manufacturing sites located in Denmark and Poland.

The Lupus Foundation of America is pleased to announce a new three-year grant, funded by the Festa Family Foundation, supporting the IMPACT study, the first trial of a biologic therapy to prevent adverse pregnancy outcomes in high-risk pregnancies in patients with antiphospholipid syndrome with or without systemic lupus erythematosus.

Flagship project launched in partnership with Edmonton International Airport to keep front-line workers safe

Combined company, to be named Palisade Bio, will be well-positioned to leverage its compelling therapeutics pipeline, strong cash position, and accomplished management and Board to maximize stockholder value

Rockwell Medical, Inc., a biopharmaceutical company dedicated to transforming the treatment of iron deficiency and anemia management and improving outcomes for patients around the world, reported financial results and a business update for the three months and full year ended December 31, 2020.

Upsized IPO in February 2021 raised $264.5 million in gross proceeds plus Series C raised $93.5 million for a total of $358 million in recent fundraising

OrthoPediatrics Corp., a company focused exclusively on advancing the field of pediatric orthopedics, announced that Dave Bailey, President, Fred Hite, Chief Operating Officer and Chief Financial Officer, and Mark Throdahl, Chief Executive Officer, are scheduled to participate in a fireside chat at the 20th Annual Needham Virtual Healthcare Conference on Tuesday, April 13, 2021.

BioXcel Therapeutics, Inc. announced topline results from its Phase 1b/2 proof-of-concept RELEASE study of BXCL501, the Company’s proprietary, orally dissolving thin film formulation of dexmedetomidine, for the treatment of opioid withdrawal symptoms.